Works matching IS 19414390 AND DT 2011 AND VI 4 AND IP 1
Results: 14
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma.
- Published in:
- Clinical Ovarian Cancer, 2011, v. 4, n. 1, p. 26, doi. 10.1016/j.cloc.2011.04.003
- By:
- Publication type:
- Article
Spontaneous Renal Pelvis Rupture Due To Ovarian Carcinoma: Case Report.
- Published in:
- Clinical Ovarian Cancer, 2011, v. 4, n. 1, p. 38, doi. 10.1016/j.cloc.2011.04.006
- By:
- Publication type:
- Article
Clinical Ovarian Cancer.
- Published in:
- 2011
- By:
- Publication type:
- Table of Contents
VEGF in the Development of Ovarian Malignancy.
- Published in:
- Clinical Ovarian Cancer, 2011, v. 4, n. 1, p. 19, doi. 10.1016/j.cloc.2011.04.007
- By:
- Publication type:
- Article
The Prognostic Value of Syndecan-1 in Ovarian Cancer Patients with Long-Term Follow up.
- Published in:
- Clinical Ovarian Cancer, 2011, v. 4, n. 1, p. 12, doi. 10.1016/j.cloc.2011.04.012
- By:
- Publication type:
- Article
Debate: Dose-Dense Paclitaxel in Combination with Carboplatin in the Management of Advanced Stage Ovarian Cancer: PRO: Dose-dense Paclitaxel in Combination with Carboplatin is an Acceptable Standard in the Front-Line Management of Advanced Stage Ovarian Cancer
- Published in:
- Clinical Ovarian Cancer, 2011, v. 4, n. 1, p. 1, doi. 10.1016/j.cloc.2011.04.011
- By:
- Publication type:
- Article
The Efficacy and Toxicity of Bevacizumab in Combination With Gemcitabine in Patients With Recurrent Ovarian Cancer.
- Published in:
- Clinical Ovarian Cancer, 2011, v. 4, n. 1, p. 34, doi. 10.1016/j.cloc.2011.04.004
- By:
- Publication type:
- Article
Luteinized Fibroma of the Ovary With Minor Sex Cord Elements: An Incidental Finding.
- Published in:
- Clinical Ovarian Cancer, 2011, v. 4, n. 1, p. 41, doi. 10.1016/j.cloc.2011.04.008
- By:
- Publication type:
- Article
Metastatic Squamous Cell Carcinoma of the Cervix Presenting as an Adnexal Neoplasm.
- Published in:
- Clinical Ovarian Cancer, 2011, v. 4, n. 1, p. 47, doi. 10.1016/j.cloc.2011.04.009
- By:
- Publication type:
- Article
CON: Dose-dense Paclitaxel at 80 mg/m2 Weekly in Combination with Carboplatin AUC-6 Every Three Weeks Should Not be Considered Standard of Care in the Front Line Management of Ovarian Cancer.
- Published in:
- Clinical Ovarian Cancer, 2011, v. 4, n. 1, p. 4, doi. 10.1016/j.cloc.2011.04.010
- By:
- Publication type:
- Article
Successful Treatment of Metastatic Squamous Cell Carcinoma of the Ovary Arising Within a Mature Cystic Teratoma.
- Published in:
- Clinical Ovarian Cancer, 2011, v. 4, n. 1, p. 44, doi. 10.1016/j.cloc.2011.04.005
- By:
- Publication type:
- Article
Isolated Myeloid Sarcoma of the Vulva.
- Published in:
- Clinical Ovarian Cancer, 2011, v. 4, n. 1, p. 49, doi. 10.1016/j.cloc.2011.04.001
- By:
- Publication type:
- Article
Outpatient Intraperitoneal Chemotherapy for All Stages of Ovarian, Fallopian Tube, and Peritoneal Cancers: A Pilot Study.
- Published in:
- Clinical Ovarian Cancer, 2011, v. 4, n. 1, p. 7, doi. 10.1016/j.cloc.2011.04.002
- By:
- Publication type:
- Article